1. Arnold, D. L., Shoubridge, E. A., Feindel, W., and Villemure, J.-G, 1987, Metabolic changes in cerebral gliomas within hours of treatment with intra-arterial BCNU demonstrated by phosphorus magnetic resonance spectroscopy, Can. J. Neurol. Sri. 14:570–575.
2. Aronen, H. J.,Gazit, I. E., Louis, D. N., Buchbinder, B. R., Pardo, F. S., Weisskoff, R. M., Harsh, G. R., Cosgrove, G. R., Halpern, E. F., Hochberg, F. H., and Rosen, B. R., 1994, Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings, Radiology
191:41–51
3. Barker, M., Hoshino, T., Gurcay, O., Wilson, C. B., Nielsen, S. L., Downie, R., and Eliason, J., 1973, Development of an animal brain tumor model and its response to therapy with 1.3-bis(2-chloroethyl)-l-nitrosourea, Cancer Res. 33:976–986.
4. Gasser, P. J., Mattiello, J., and LeBihan, D., 1994, MR diffusion tensor spectroscopy and imaging, Biophys. J. 66:259–267.
5. Ben-Horin, H., Tassini, M., Vivi, A., Navon, G., and Kaplan, 0., 1995, Mechanism of action of the antineoplastic drug lonidamine: 31Р and 13С nuclear magnetic resonance studies, Cancer Res. 55:2814–2821.